Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus

Objective: To perform a randomized, placebo-controlled, double-blind study, with a follow-up period of 6 months, for the use of topical clobetasol in cases of symptomatic oral lichen planus (OLP). Subjects and Methods: Thirty-two participants were analyzed, with the aims of: (I) to compare the usefu...

Full description

Bibliographic Details
Main Authors:	Arduino, P.G (Author), Broccoletti, R. (Author), Cabras, M. (Author), Campolongo, M.G (Author), Carbone, M. (Author), Carossa, S. (Author), Conrotto, D. (Author), Gambino, A. (Author), Ricceri, F. (Author), Sciannameo, V. (Author)
Format:	Article
Language:	English
Published:	Blackwell Publishing Ltd 2018
Subjects:	Administration, Topical adult aged Aged antiinflammatory agent Anti-Inflammatory Agents Article clinical article clobetasol Clobetasol clobetasol propionate controlled study double blind procedure Double-Blind Method drug withdrawal erythema female Female follow up gastroesophageal reflux glucose glucose blood level human Humans hydroxyethylcellulose lichen planus Lichen Planus, Oral male Male medication compliance middle aged Middle Aged oral lichen planus outcome patient compliance placebo priority journal randomized controlled trial remission side effect symptomatic topical drug administration treatment outcome Treatment Outcome
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus

Internet

Similar Items